What Is The Long-Term Forecast For The Cold Remedies Market Growing At 5.9% CAGR?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Are The Market Size Estimates For The Cold Remedies Market?
The market size for cold remedies has seen considerable growth in the recent past. Projected to increase from $9.31 billion in 2024 to $9.82 billion in 2025, the compound annual growth rate (CAGR) is estimated at 5.4%. The historical growth is primarily due to the increasing occurrence of respiratory infections, the surge in the elderly population, the need for efficient combination products, a significant transition from the Rx to the OTC category, and the escalating consumer demand for efficient alleviation.
Over the coming years, the cold remedies market is predicted to experience significant expansion, reaching an estimated value of $12.35 billion by 2029 with a compound annual growth rate (CAGR) of 5.9%. This anticipated growth within the forecast period can be credited to factors such as heightened research and development investment, growing cognizance of proactive health care, the rise in holistic methodologies, increased health awareness, as well as supportive government policies. Key trends expected to emerge within the forecast period encompass the development of novel solutions, advancement in technology, innovative formulations, individualized medication, and a transition towards personalized and immunity-enhancing solutions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23347&type=smp
Which Industry Forces Are Driving The Cold Remedies Market Forward?
The increasing occurrence of respiratory infections is predicted to spur the expansion of the cold remedies market. Respiratory infections, caused by viruses, bacteria, or other types of pathogens, impact the respiratory system, including the lungs, airways, throat, and sinuses. The growth in these infections can mainly be attributed to impaired immunity due to less exposure to viruses during pandemic-induced lockdowns and social distancing. Cold remedies assist in managing respiratory infections by reducing symptoms such as sore throat, cough, and congestion, providing comfort as the immune system combats the root infection. For instance, the Office for National Statistics, a government agency based in the UK, reported in March 2023 that in England, COVID-19 infections spiked. Approximately 2.66% of the population tested positive (1 in 40 people), and hospital admissions escalated to 10.62 per 100,000 individuals. Hence, the increasing occurrence of respiratory infections is fueling the expansion of the cold remedies market.
Which Segment Accounts For The Largest Share In The Cold Remedies Market?
The cold remedies market covered in this report is segmented –
1) By Drug Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Other Drugs
2) By Dosage Type: Oral Syrups, Tablets And Pills, Nasal Drops, Lozenges, Other Dosage Types
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets And Hypermarkets, E-Commerce And Online Pharmacies
Subsegments:
1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines
2) By Expectorants: Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants
3) By Bronchodilators: Beta-Agonists, Anticholinergics, Methylxanthines
4) By Decongestants: Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants
5) By Antibiotics: Penicillin-Based Antibiotics, Macrolides, Cephalosporins
6) By Other Drugs: Pain Relievers, Cough Suppressants, Herbal And Homeopathic Remedies
Which Long-Term Trends Will Play A Crucial Role In The Cold Remedies Market?
In an attempt to cater to the increasing demand for more natural and safe alternatives, key players in the cold remedies market are concentrating their efforts on creating innovative products like chemical-free cough and cold medicines. These products are made without the use of artificial coloring agents, sweeteners, preservatives, or typical allergens and use natural or organic components instead for a more secure alleviation of symptoms. An example of this is Genexa Inc., a medical firm based in the United States, which introduced in September 2023 a new line of chemical-free cough and cold medications for children. These include the Kids’ Multi-Symptom Cold And Flu and Kids’ Daytime + Nighttime Cough Relief Value Pack, products which don’t include common allergens or artificial additives like sweeteners or dyes and instead, use organic agave syrup as a healthier substitute for artificial fillers. Even though they employ the same effective ingredients, it’s done in a safe, non-toxic arrangement improving the overall trust among consumers.
Which Players Are Shaping The Competitive Landscape Of The Cold Remedies Market?
Major companies operating in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., Fibovil Pharmaceuticals Pvt. Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cold-remedies-global-market-report
What Regional Factors Are Accelerating Growth In The Cold Remedies Market?
North America was the largest region in the cold remedies market in 2024. The regions covered in the cold remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23347&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
